TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Osiris suffers another stem cell setback Osiris Therapeutics Inc. suffered another setback for plans to commercialize its stem cell drug Prochymal, as the drug proved no better than a placebo in two final trials. (OSIR) feeds.bizjournals.com |
Orthopedists Fail to Disclose Payments Orthopedists failed to disclose more than 20% of the payments they receive from makers of hip and knee replacements when presenting research related to the companies' products. online.wsj.com |
[$$] LabCorp Shares Can Pass the Test (at Barrons.com) LabCorp Shares Can Pass the Test Despite jitters over health-care reform, this medical-lab company may have just what the doctor ordered. us.rd.yahoo.com |
All Eyes on Cel-Sci: Will Wednesday's Surge Continue? VFC submits: With a late day surge of nearly twenty cents on Wednesday, Cel-Sci (CVM) will be a stock to watch during Thursday's trading. Investors will be looking for indications of whether or not the move was for real, and marking the end of the recent downtrend.With a late day surge like the one CVM enjoyed, it's possible that news is brewing and a PR is pending, but it's also possible that it could just be another head fake, possibly the result of manipulation, and the stock will continue to trade down for the short term.Complete Story » seekingalpha.com |
Cord Blood America Announces Contract With BioE; Provides Clients Highest Quality, 'State of the Art' Processing System for Cord Blood Storage (PR Newswire) Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has contracted with BioE, St. us.rd.yahoo.com |